Discover
COCP
Cocrystal Pharma, Inc.
1.05
2 x 0.76
2 x 1.36
bid
ask
+
0.00
0.00%
2 @ 06:12 AM
1.03 -0.02 (1.72%)
| Ytd | 7.14% | |
| 1y | -29.53% |
1.05
day range
1.07
0.86
52 week range
2.67
| Open | 1.06 | Prev Close | 1.05 | Low | 1.05 | High | 1.07 | Mkt Cap | 14.48M |
| Vol | 34.99K | Avg Vol | 2.47M | EPS | -0.72 | P/E | N/A | Forward P/E | -1.22 |
| Beta | 1.45 | Short Ratio | 0.12 | Inst. Own | 6.94% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 1.17 | 200-d Avg | 1.12 | 1yr Est | 8.00 |
| Income Statement | |||
| Operating Expenses | 2.58M | ||
| Research and Development Expense | 1.37M | ||
| Selling, General and Administrative Expense | 1.21M | ||
| Operating Income | -2.58M | ||
| Net Income | -2.30M | ||
| Net Income Common Stock | -2.30M | ||
| Net Income Common Stock (USD) | -2.30M | ||
| Consolidated Income | -2.30M | ||
| Earnings per Basic Share | -0.17 | ||
| Earnings per Basic Share (USD) | -0.17 | ||
| Earnings per Diluted Share | -0.17 | ||
| Earning Before Interest & Taxes (EBIT) | -2.30M | ||
| Earning Before Interest & Taxes (USD) | -2.30M | ||
| Weighted Average Shares | 13.79M | ||
| Weighted Average Shares Diluted | 13.79M | ||
| Balance Sheet | |||
| Cash and Equivalents | 4.86M | ||
| Cash and Equivalents (USD) | 4.86M | ||
| Trade and Non-Trade Receivables | 70.00K | ||
| Current Assets | 5.94M | ||
| Property, Plant & Equipment Net | 1.39M | ||
| Total Assets | 7.43M | ||
| Debt Current | 343.00K | ||
| Total Debt | 1.42M | ||
| Current Liabilities | 2.23M | ||
| Debt Non-Current | 1.08M | ||
| Total Liabilities | 3.31M | ||
| Accumulated Retained Earnings (Deficit) | -344.55M | ||
| Shareholders Equity | 4.12M | ||
| Shareholders Equity (USD) | 4.12M | ||
| Assets Non-Current | 1.49M | ||
| Total Debt (USD) | 1.42M | ||
| Liabilities Non-Current | 1.08M | ||
| Trade and Non-Trade Payables | 1.89M | ||
| Tax Assets | 691.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 12.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.34M | ||
| Net Cash Flow from Operations | -2.34M | ||
| Share Based Compensation | 84.00K | ||